Julio Montaner chercheur
González Montaner, Julio Sergio, 1956-
Montaner, Julio
Montaner, Julio S. G.
Montaner, Julio 1956-
VIAF ID: 121097743 (Personal)
Permalink: http://viaf.org/viaf/121097743
Preferred Forms
-
100 1 _
‡a
González Montaner, Julio Sergio,
‡d
1956-
-
100 0 _
‡a
Julio Montaner
‡c
chercheur
-
100 1 _
‡a
Montaner, Julio
-
100 1 _ ‡a Montaner, Julio
-
100 1 _
‡a
Montaner, Julio
-
100 1 _ ‡a Montaner, Julio S. G.
-
100 1 _
‡a
Montaner, Julio
‡d
1956-
4xx's: Alternate Name Forms (20)
Works
| Title | Sources |
|---|---|
| Closing the implementation gap to stop HIV/AIDS, 2010: |
|
| Expertní prohlášení k vědeckým poznatkům o HIV v kontextu trestního práva |
|
| Mepron®, Atovaquone therapy in pneumocystis carinii pneumonia |
|
| Prognostic staging of extensively pretreated patients with advanced HIV-1 disease |
|
| Programmatic Implications of Acute and Early HIV Infection |
|
| Progress towards the United Nations 90-90-90 and 95-95-95 targets: the experience in British Columbia, Canada |
|
| Prospective, randomized, open label trial of Efavirenz vs Lopinavir/Ritonavir in HIV+ treatment-naive subjects with CD4+<200 cell/mm3 in Mexico |
|
| Protocol of the impact of alternative social assistance disbursement on drug-related harm (TASA) study: a randomized controlled trial to evaluate changes to payment timing and frequency among people who use illicit drugs |
|
| Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver |
|
| Psychosocial issues influencing treatment adherence in patients on multidrug rescue therapy: perspectives from patients and their health care providers |
|
| Public crack cocaine smoking and willingness to use a supervised inhalation facility: implications for street disorder. |
|
| Randomized, controlled study of the effects of a short course of prednisone on the incidence of rash associated with nevirapine in patients infected with HIV-1. |
|
| Rates and predictors of injury in a population-based cohort of people living with HIV: trends and disparities from 1996 to 2013. |
|
| Rates of Prescribing Zidovudine Post Concorde Trial |
|
| Realizing the potential of treatment as prevention: global ART policy and treatment coverage |
|
| Reducing rates of preventable HIV/AIDS-associated mortality among people living with HIV who inject drugs |
|
| Reduction of HIV incidence in men who have sex with men |
|
| Regional and temporal trends in migration among people living with HIV/AIDS in British Columbia, 1993-2005. |
|
| Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries |
|
| The relationship between resistance and adherence in drug-naive individuals initiating HAART is specific to individual drug classes |
|
| The relationship between social, policy and physical venue features and social cohesion on condom use for pregnancy prevention among sex workers: a safer indoor work environment scale |
|
| Relative effects of antiretroviral therapy and harm reduction initiatives on HIV incidence in British Columbia, Canada, 1996-2013: a modelling study |
|
| Residential Eviction and Risk of Detectable Plasma HIV-1 RNA Viral Load Among HIV-Positive People Who Use Drugs |
|
| Resolution of diabetes after initiation of antiretroviral therapy in two human immunodeficiency virus-infected patients |
|
| Response to Lancaster et al. Generalizability and scalability of HIV 'treatment as prevention'. |
|
| Retention in care and mortality trends among patients receiving comprehensive care for HIV infection: a retrospective cohort study |
|
| Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study |
|
| Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level |
|
| Risks surrounding drug trade involvement among street-involved youth |
|
| Ritonavir-boosted protease inhibitors in HIV therapy |
|
| Safety and efficacy of once-daily nevirapine dosing: a multicohort study |
|
| Safety and tolerability of combination antiretroviral post-exposure prophylaxis in a population-based setting |
|
| Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeks |
|
| Safety, tolerability, and preliminary efficacy of 48 weeks of etravirine therapy in a phase IIb dose-ranging study involving treatment-experienced patients with HIV-1 infection |
|
| Science and politics of heroin prescription |
|
| Seek and treat to optimize HIV and AIDS prevention |
|
| Selected topics from the 10th Conference on Retroviruses and Opportunistic Infections. |
|
| Self-management of pain among people who inject drugs in Vancouver |
|
| Seroadaptive Strategies of Gay & Bisexual Men (GBM) with the Highest Quartile Number of Sexual Partners in Vancouver, Canada |
|
| Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injecting facility. |
|
| Severe food insecurity is associated with elevated unprotected sex among HIV-seropositive injection drug users independent of HAART use |
|
| Sex-Based Differences in Rates, Causes, and Predictors of Death Among Injection Drug Users in Vancouver, Canada |
|
| Short communication. Association of the CCR5delta32 mutation with clinical response and >5-year survival following initiation of first triple antiretroviral regimen |
|
| Should active recruitment of health workers from sub-Saharan Africa be viewed as a crime? |
|
| Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history |
|
| Simplification of therapeutic drug monitoring for twice-daily regimens of lopinavir/ritonavir for HIV infection |
|
| Simplified HIV Testing and Treatment in China: Analysis of Mortality Rates Before and After a Structural Intervention |
|
| Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs. |
|
| Social and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapy |
|
| Social and structural factors associated with greater time with a plasma HIV-1 RNA viral load above log10(1500) copies/ml among illicit drug users. |
|
| Social-structural factors associated with supportive service use among a cohort of HIV-positive individuals on antiretroviral therapy |
|
| Socializing in an open drug scene: the relationship between access to private space and drug-related street disorder |
|
| Sociodemographic disparities in access to addiction treatment among a cohort of Vancouver injection drug users. |
|
| Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996. |
|
| Special Access Denied: A Case Study of Health Canada's Special Access Program |
|
| Special considerations in the initiation and management of antiretroviral therapy in individuals coinfected with HIV and hepatitis C. |
|
| The spread of hepatitis C virus genotype 1a in North America: a retrospective phylogenetic study |
|
| Sticking to it: the effect of maximally assisted therapy on antiretroviral treatment adherence among individuals living with HIV who are unstably housed |
|
| Stopping antiretroviral therapy: easier said than done |
|
| Street-level policing in the Downtown Eastside of Vancouver, Canada, during the 2010 winter Olympics |
|
| Structural Barriers to Antiretroviral Therapy Among Sex Workers Living with HIV: Findings of a Longitudinal Study in Vancouver, Canada |
|
| Structural factors associated with an increased risk of HIV and sexually transmitted infection transmission among street-involved youth. |
|
| Suboptimal biological sampling as a probable cause of false-negative COVID-19 diagnostic test results |
|
| Suboptimal plasma HIV-1 RNA suppression and adherence among sex workers who use illicit drugs in a Canadian setting: an observational cohort study |
|
| Substance use, sexual behaviour and prevention strategies of Vancouver gay and bisexual men who recently attended group sex events |
|
| Suicide mortality among people accessing highly active antiretroviral therapy for HIV/AIDS in British Columbia: a retrospective analysis |
|
| Supervised injecting facilities: time for scale-up? |
|
| Survival rates after the initiation of antiretroviral therapy stratified by CD4 cell counts in two cohorts in Canada and the United States |
|
| Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes |
|
| The T cell receptor V beta repertoire shows little change during treatment interruption-related viral rebound in chronic HIV infection |
|
| Technical and regulatory shortcomings of the TaqMan version 1 HIV viral load assay |
|
| The temporal relationship between drug supply indicators: an audit of international government surveillance systems |
|
| Tenofovir-based rescue therapy for advanced liver disease in 6 patients coinfected with HIV and hepatitis B virus and receiving lamivudine |
|
| Testing and linkage to HIV care in China: a cluster-randomised trial |
|
